Canada Pension Plan Investment Board’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98K Buy
397,100
+145,200
+58% +$57.8K ﹤0.01% 1650
2025
Q4
$106K Buy
+251,900
New +$134K ﹤0.01% 1802
2014
Q2
Sell
-1,500
Closed -$27K 1290
2014
Q1
$27K Sell
1,500
-2,600
-63% -$50.1K ﹤0.01% 1209
2013
Q4
$57K Sell
4,100
-2,000
-33% -$23K ﹤0.01% 1089
2013
Q3
$64K Buy
+6,100
New +$60.6K ﹤0.01% 951

Other funds holding SGMO

Canada Pension Plan Investment Board's SGMO Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 58% in Q1 2026, buying an estimated $57.8K and bringing the position to 397,100 shares worth $98K. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

Canada Pension Plan Investment Board first reported a position in SGMO in Q3 2013 and has held it in 5 quarters since. The position peaked at $106K in Q4 2025. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Canada Pension Plan Investment Board held 397,100 shares of SANGAMO THERAPEUTICS INC worth $98K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 145,200 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $57.8K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1650 holding.
  • Canada Pension Plan Investment Board first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and has held it in 5 quarters since.
  • Canada Pension Plan Investment Board's SANGAMO THERAPEUTICS INC position peaked at $106K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.